Reversed-phase high-performance liquid chromatography (RP-HPLC) of therapeutic proteins continues to play a significant role in product characterization. This study focuses on two key aspects of HPLC method development, namely the selection of organic modifier and the gradient shape. Separation of granulocyte colony-stimulating factor variants is being used as a case study to illustrate these concepts. The results demonstrate that careful selection of a binary or ternary mixture of solvents with water is an important factor to be considered for achieving the desired resolution of closely related impurities. The resolution of different types of impurities has been shown to be selective toward the choice of eluent along with the ratio in which they are mixed. In addition, this study also presents a systematic approach for selection of gradient shape based on center point solvent composition, initial solvent composition and the steepness of the gradient. The approach proposed in this study was successfully used to reduce the time of analysis from 70 min for the pertinent European Pharmacopeia method to 15 min by using a solvent system with two organic modifiers (acetonitrile and methanol) along with a sigmoidal-shaped gradient.
Introduction
Heterogeneity that is typical in biotech therapeutics requires thorough characterization using multiple orthogonal techniques for receiving regulatory approval to commercialize the product (1 -4) . One such technique that is successfully employed is reversed-phase high-performance liquid chromatography (RP-HPLC). With the rise of biotherapeutics in the recent decade and the enhanced sensitivity that RP-HPLC offers toward detecting minor changes in protein structure, it has served as a work horse for analysis and purification of wide range of commercially important products for several decades (5) . Analytical RP-HPLC method development for proteins can, however, be a complex process (6) . This is primarily due to the large number of parameters that can impact the resolution of the method. These include column chemistry, solvent system, temperature, gradient shape and flow rate. These parameters may also interact among themselves and thereby impact method performance. Several approaches have been described in the literature for method development and optimization (7) . Major criteria to judge method performance for RP-HPLC are selectivity and resolution (8) (9) (10) (11) . Both largely depend on solvent type, solvent strength (12 -15) , column chemistry (16) and strength of ion-pair reagent (17) (if samples are ionic in nature). They are typically optimized by altering solvent composition (water and two to three organic modifiers), and this may require a large number of experimental trials based on statistical designs (14, (18) (19) (20) (21) . Beside experimental trials, computer programs based on various retention models are also used for method optimization (22 -27) .
If the sample contains many heterogeneous components, optimum separation is unlikely in the isocratic mode of elution. Moreover, the time of analysis may be quite large for elution of all the components. In such cases, elution is often accomplished by applying a gradient based on a binary or ternary mixture of solvents selected in view of selectivity toward components (28 -31) . Method development of such a gradient method requires optimization of its steepness, range and shape (32 -38) . The shape of gradient can be linear, segmented linear or nonlinear. Linear gradients are often preferred because they are easy to optimize and operate. They can be easily converted into segmented linear gradient to reduce run time if peaks are widely/ non-uniformly distributed. A more sophisticated method could be the use of nonlinear gradient shape (concave up, concave down or their mixture) (39 -41) . Nonlinear gradients can have distinct advantages such as reduced separation time, improved sample resolution and/or increased detection sensitivity. Challenges in optimization of nonlinear gradients include optimization of start and end mobile phase composition and the steepness factor for the shape chosen. Nonlinear gradients have been successfully developed using retention time models (39 -41) . These models can easily explain the need of such shapes given the protein selectivity on RP-HPLC column. Still, these models are not simple and their adoption in method development can be a challenge (42, 43) .
Granulocyte colony-stimulating factor (GCSF), also known as filgrastim, is a cytokine produced by macrophages, endothelial cells, monocytes and fibroblasts. Human GCSF consists of 174 amino acids with an approximate molecular weight of 19.60 kDa (44) . GCSF plays a critical role in the modulation of the neutrophil biology (45) and has been approved by the US FDA, EMA and several other regulatory agencies for use in chemotherapy-induced neutropenia. It contains an additional N-terminal methionine, which is essential for its expression in Escherichia coli cells. Oxidized and reduced variants of the GCSF are two of the most critical product-related impurities, which have been known to impact the safety and efficacy of the product (4) . RP-HPLC is presently the primary analytical tool used for quantification of the product-related variants (oxidized, main and reduced species) in view of the difference in the hydrophobicity of these variants (46) . Currently, characterization of GCSF is performed using the established European Pharmacopeia (EP) method for RP-HPLC (47) . It uses a segmented linear gradient consisting of an organic modifier (acetonitrile). The time of analysis for this method is 70 min with a C4 Phenomenex RP column.
This study focuses on two key aspects of method development, namely the selection of organic modifier and gradient shape. Separation of GCSF variants is being used as a case study to illustrate these concepts. Optimization of elution phase composition has been demonstrated to be critical for obtaining a good resolution. In addition, this study also presents a systematic approach for selection of gradient shape based on center point solvent composition, initial solvent composition and the steepness of the gradient. The approach proposed in this study has been shown to be successfully used to reduce the time of analysis from 70 min for the above-mentioned EP method to 15 min by using a solvent system with two organic modifiers (acetonitrile and methanol) along with a sigmoidal-shaped gradient. The proposed method offers equivalent resolution of identified peaks.
Theory
Gradient elution is widely used for separation of complex samples in HPLC. Linear gradients are preferred due to the ease of operation and implementation. However, as is the case with the application under consideration, the properties of the various analytes can be such that there is a significant difference in their retention times resulting in a long time of analysis when using a linear gradient. The spacing between the peaks and thus the time of analysis can be significantly decreased by segmenting and optimizing the different parts of the gradient. This optimization can result in a step gradient consisting of several subsequent isocratic steps corresponding to different mobile phase compositions, or in segmented gradients with a sequence of linear gradients of different duration and steepness. Researchers working on RP-HPLC of proteins have shown that changing the concentration of the solvent by just a few percent can result in major changes in the elution behavior of the target species (48) . As a result, plots of capacity factor vs. eluting solvent concentration are very nonlinear (concave). It can thereby be concluded from this discussion that the optimum shape employed in most applications would be nonlinear. The downside of using nonlinear gradients, however, is the complexity of method optimization as this would require experimental determination of a lot of model parameters. As a result, use of nonlinear gradients is not very popular in the industry.
In this study, we proposed a step-by-step approach to build a nonlinear gradient using a simple equation having parameters consisting of initial solvent composition (B 0 ), mid-/end-level solvent composition (B f ) and steepness factor (n).
If t is the interval between change in gradient percentage, and t f is the total number of intervals of gradient change, T the total time of the linear, concave-up and concave-down gradient, then B% can be approximated by using the following equation:
where B 0 is the initial solvent composition and B f is the mid-/ end-level solvent composition.
At the time points, Tp(t)
Furthermore, C(t) is the function of t given by the following equations:
Cðt Þ ¼ t =t f ; for linear gradient or; ð3Þ
Cðt Þ ¼ ðt =t f Þ n ; for concave-up gradient ð5Þ
where n is the number controlling the steepness (concavity) of gradient shape. Though in most cases, either concave-up or concave-down shape yields satisfactory results (48) , in some cases where the sample contains a main component and other closely related variants, the gradient slope at the point of elution of the main component should be the shallowest. This can be achieved by applying a mixture of concave-down (equation 4) and concave-up gradients (equation 5). To make a smooth transition from concave-down to concave-up mode, the parameter B 0 of concave-up shape can be made equal to B f of concave-down shape. The final shape that will result will be a sigmoidal one. This shape ensures that the shallowest slope is applied during elution of the main component and steep slope is applied during elution of the other components that elute before or after the main component. Furthermore, steepness for first half or later half can be controlled independently by varying "n".
Gradient shape optimization results in reduction in time of analysis and increases in peak resolution based on capacity factor. Before optimization of nonlinear gradient shape, the other important aspect that should be considered is that of selectivity of the sample components as related to the solvent system. The three major solvent systems that are commonly used in RP-HPLC are iso-propyl alcohol (IPA), acetonitrile (ACN) and methanol (MeOH), in an increasing order of retention time. To begin with, concentration of one organic solvent can be kept constant while a gradient can be formed between the other organic solvent and water, and the selectivity can be monitored. Once selectivity has successfully been correlated to the solvent system, then based on resolution, concentration of one solvent can be kept constant, whereas other can be operated in a gradient mode. It may be difficult to operate both in a gradient mode as the system may become too complex and robustness may suffer.
Experimental

Protein samples
The therapeutic protein sample used in this study was that of recombinant human GCSF (E. coli derived) and was generated in our laboratory using inclusion bodies donated from a major domestic biotech manufacturer.
Instrumentation and columns
Analytical chromatographic experiments in this work were performed using an Acquity H-Class UPLC (Waters Corporation, Milford, MA, USA) equipped with a quaternary solvent pump, an auto sampler and a photodiode array detector. Instrument control, data acquisition and compilation of results for UPLC were performed using the Waters Empower-II software (Waters Corporation).
Three reversed-phase columns were examined in this study (i) C4 Column (5 mm, 4.6 mm Â 250 mm) from Phenomenex, (ii) X-bridge TM BEH300 C4 3.5 mm, 4.6 Â 250 mm column from Waters and (iii) X-bridge TM BEH300 C4 3.5 mm, 4.6 Â 150 mm column from Waters. Columns from Waters were operated at a flow rate of 0.8 mL/min, whereas the one from Phenomenex was operated at 0.6 mL/min.
Mobile phase preparation
Acetonitrile, methanol, isopropanol, trifluoroacetic acid (TFA) and Milli-Q water used in the experiments were of HPLC grade and were procured from Merck, India. These organic phases were prepared with appropriate mixing of 99.9% organic phase and 0.1% TFA, filtered with a 0.22-mm nylon membrane filter and degassed before usage.
Nomenclature of peaks GCSF as resolved on analytical RP-HPLC was identified with six distinct peaks and these have been named as Oxd1, Oxd2, Native, Red1, Red2 and Aggregate. Figure 1 shows a chromatogram and illustrates the location of each of these peaks.
Results
The standard RP-HPLC method from the EP monograph for GCSF recommends use of a C4 Phenomenex column and consists of a segmented gradient of ACN/water from 55 to 99% with 0.1% TFA as the ion-pair reagent at 608C and a time of analysis of 70 min (48) . Figure 1 illustrates a chromatogram of a typical sample using this method. A close examination of the distribution of the oxidized, reduced and aggregate peaks indicates that the peaks are not uniformly spaced and this provides an opportunity for use of nonlinear gradient as a possible approach to significantly reduce the time of analysis (39 -41, 48) . Furthermore, the EP method uses a single organic system in the gradient and it is seen that the variants that are close to the product peak are not well resolved.
In this study, we developed an alternative method to the EP method based on the BEH 300 C4 Waters columns with a smaller bead size (1.7 mm) than the Phenomenex column (5 mm). To improve the resolution, possibility of using a two-component organic system consisting of ACN/MeOH or ACN/IPA was examined. The ion-pair reagent (0.1% TFA) and temperature (608C) were maintained similar to the EP method.
Role of solvents in selectivity
The strength of the solvents examined was in the order MeOH , ACN for eluting out GCSF and its variant. This was confirmed by applying a linear gradient of ACN from 30 to 100% in 35 min (Figure 2A ) and MeOH from 70 to 100% in 12.5 min ( Figure 2B ) with the C4 BEH 300, 25 cm Waters column. It was observed that the oxidized impurity OXD2 is better resolved with the ACN gradient, whereas the reduced impurity RED1 was better resolved with the MeOH gradient. The effect of the organic solvent gradient on the selectivity of oxidized and reduced species was examined in detail by using ACN in an isocratic mode (10 and 20%) and MeOH in a gradient mode (60-90% and 50-80%). It was observed that use of the methanol gradient helped in resolving the Red1 impurity completely from the native peak ( Figure 2C and D) . Also, when the % of ACN was changed to a higher value in the isocratic mode, it resulted in an improvement in the resolution of Oxd2 impurity. In another case, MeOH was used in the isocratic mode (25 and 20%) and ACN was operated in the gradient mode (35 -65% and 30 -80%). Figure 2E and F clearly shows that use of ACN in the gradient mode (35 -65%) with methanol in the isocratic mode (15 -20%) resulted in an improved resolution of the various impurities in comparison with the EP method. The binary system clearly emerged as a better option if close variants are to be resolved. ACN in the gradient mode (35 -65%) with MeOH (25%) in the isocratic mode was found to yield a better resolution (higher dip from main peak), compared with ACN (20%) in the isocratic mode and MeOH in the gradient mode (50 -85%).
The solvent system with IPA did not improve selectivity for either RED2 or OXD1 impurities; hence, it was not further examined in this study. The ACN/MeOH system was chosen as the optimal mixture with ACN in the gradient mode (35 -65%) and MeOH (25%) in the isocratic mode. In the next section, we explore the impact of gradient shape on reduction in the time of analysis and sharpness of the resulting peaks.
Role of gradient shape
Based on the elution pattern for the application at hand (Figure 1) , it is observed that the peaks are not uniformly spaced and so the possibility of use of nonlinear gradients was examined and both the concave-up and sigmoidal-shaped gradients were examined.
Concave-up gradient shape
The important parameters that need to be determined to obtain a concave-up gradient shape for ACN were B 0 , B f and steepness factor (n). Of these three factors, B 0 and B f were directly obtained from experiments performed with the linear gradient. Care was taken to subtract column void volume when determining these parameters and a 5% margin was kept from the main component as the initial value of the solvent system. The value of n was optimized in steps of 0.5 until the desired resolution was obtained. The results for "n" ¼ 1.5 and 2 with a time of analysis of 15 min on a 15-cm column are shown in Figure 3A and B, respectively. As the concavity increases, the resolution is seen to increase but it is not satisfactory for quantification of these peaks (mainly OXD2). Hence, sigmoidal-shape gradient was examined as an alternative.
Sigmoidal-shape gradient
Based on the distribution of the various peaks (Figure 1) , a sigmoidal gradient consisting of a combination of concave down for first half and concave up for second half of the gradient shape was examined. Optimization was performed in three steps using a 15-cm column and a time of analysis of 15 min.
First involved optimization of the center point (B f of concavedown shape ¼ B 0 of concave-up shape), second involved optimization of the initial composition (B 0 of concave down) and finally, the third involved optimization of the steepness factor "n". The rationale of optimizing in this order is based on importance of these parameters.
The resolution of main component is most important and hence it is desirable to have a flat (or shallow-shaped) gradient during elution. Though center point can be directly obtained from experiments performed using the linear gradient, retention in RP-HPLC also depends on the slope of the linear gradient and thus a separate examination was performed. Three points were chosen (42, 45 and 48% ACN), and "n" and B 0 values were fixed at 2 and 35% ACN, respectively. The MeOH concentration was also kept fixed at 25% for all runs in the isocratic mode. Figure 4A -C illustrates the results obtained with a 15-cm column. The value of B f was finalized to be 45% ACN as both the OXD 2 and RED1 impurities were better resolved with this composition when compared with that at 42 and 48%. Further optimization of the initial composition and the steepness factor was performed.
Initial composition and value of steepness factor "n" both determine the concavity of the gradient. The initial condition chosen from Figure 2C to F was 35% ACN which was varied by +3% (32, 35 and 38%), and for all these initial conditions, the value of "n" was also varied (1.5, 2 and 2.5). The results indicate that initial percentage of 35% was found to resolve Oxd2 and Red1 impurities better than at 32 and 38% ( Figure 4D -F) . Furthermore, "n" was also found to impact peak sharpness and hence was optimized so as to decrease the irregularities in the chromatogram and thereby reduce the time of analysis. Thus, after finalizing B 0 and B f and choosing the end %B to be 65%, the method was subjected to different values of n to improve the resolution. At B 0 of 35% and B f of 45%, n was varied from 1.5 to 2.5. With an increase in "n" value, the analysis time reduced but there was no significant difference in the resolution of the chromatogram (data not shown). Thus, a "n" value of 2 was selected for further experiments.
Applicability of gradient shape toward columns of different lengths To establish that the gradient shape obtained is optimum and will give similar or optimum resolution if the column length is changed, the method was performed using a 25-cm column. An increase in length of the column means higher column volume (CV) and hence the time interval of gradient run must be changed while changing the length of the column. So, the overall gradient length was extended as per the ratio of the CV of the two columns. The final result is shown in Figure 5 , and the time points and solvent compositions are summarized in Table I . As expected, the resolution obtained was better with the 25-cm column ( Figure 5A ) when compared with the 15-cm column ( Figure 5B ) due to the higher bed height of the column without any loss of resolution, thus demonstrating the utility of the proposed approach. Furthermore, the column was operated at the upper range of the recommended flow rate so as to minimize the time of analysis.
Discussion
The study addresses two aspects of RP-HPLC method development, namely the role of organic modifier and the gradient shape. During optimization of the former, it was observed that different solvent systems play a varying role in selectivity of different species. In particular, this selectivity played an important role if the impurities are closely related. For example, the resolution of OXD1 and RED2 was not affected by altering the solvent system, but the resolution of OXD2 and RED1 was significantly enhanced. Another key aspect was the use of organic modifier in a gradient or in an isocratic mode. In general, the use of multiple organic modifiers in the gradient mode was found to enhance the separation by giving more control but at the same time added to the complexity of system. We also used MeOH in the isocratic mode and ACN in the gradient mode. It must be noted that while for the present case ACN was better than methanol, the selectivity of organic modifier is likely to vary from system to system.
In the second part of this study, initial composition of solvent and the gradient shape were optimized. Since the gradient shape and initial condition are interrelated, experiments with all the combinations of gradient shape and initial conditions were performed. We recommend that the initial solvent composition should not be too close to elution conditions as this may result in a decrease in robustness of the method. Typically, the % elution buffer required for sample elution depends on the overall strength of organic modifiers. In our case, samples eluted between 50 and 60% of ACN and so a 5% lower solvent strength was used as an initial guess for the optimization study.
In general, it can be concluded that a nonlinear sigmoidal shape is likely to perform better than concave-up or concavedown shape. The reason being that there will always be a main component and it would always be better to obtain a shallowest gradient during its elution to achieve maximum resolution. A sigmoidal shape best suits the purpose as demonstrated in this study. For our case, the required steepness was optimized and the resolution was found to be better at "n" ¼ 2.5. This could also be controlled by the range of solvent strength between B 0 and B f . But, it would always be desirable to keep the difference between B 0 and B f to minimum if shorter run time has to be obtained. In case of GCSF, the B 0 and B f of the concave-down part were found to be 35 and 45%, respectively, whereas those of concave-up part were 45 to 65%, respectively. The optimal gradient shape obtained was found to be independent of column length and flow rate. This was demonstrated by using the same gradient shape (i.e., same B 0 , B f and n) over columns of 15 and 25 cm length.
Conclusions
A method for quantification of oxidized and reduced variants of GCSF was developed. A careful selection of a binary or ternary mixture of solvent was performed to maximize the selectivity of closely related impurities thereby resulting in the desired resolution of these peaks. To further enhance the uniformity of the peaks with respect to their retention times in the chromatogram, a nonlinear gradient was chosen and its shape optimized. Effects of concave-up and sigmoidal-shapes gradient on resolution were compared. An approach toward development of the sigmoidalshape gradient was established and the final method resulted in uniformly spaced peaks with a considerably shorter time of analysis. The transferability of this method from a smaller to longer column or vice versa was also demonstrated. 
